Fidelity MSCI健康照護指數ETF FHLC 深 滬
等待開盤 08-21 09:30:00 美东时间
83.64
-1.550
-1.82%
華盛通- 最 高84.865
- 今 開84.50
- 成交量 23.92万股
- 最 低 83.60
- 昨 收 85.19
- 總市值 349.20万
- 52周最高 85.4649
- 市盈率 靜 --
- 換手率 572.96%
- 52周最低 63.536
- 委 比 -59.65%
- 總股本 4.18万
- 歷史最高 85.4649
- 量 比 1.27
- 振 幅 1.48%
- 歷史最低 15.491
- 每 手 1
- 風險率 4.36%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Healthcare ETFs rally as Moderna nearly doubles on melanoma win
Several healthcare focused exchange traded funds advanced on Wednesday after Moderna (MRNA) shares surged nearly +100%. The move followed positive late-stage trial results for Intismeran Autogene, an ...
08-19 21:13
Corcept, Revolution Medicines lead ten large-cap healthcare stocks surging in 2026
As the Q2 earnings season draws to a close, investors are turning their attention to broader metrics to identify sustainable market leaders. With corporate report cards nearly finalized, assessing yea...
08-17 20:26
Earnings optimism broadens: health care, industrials, and real estate join tech
Corporate earnings season is delivering an unusually strong signal of confidence as a growing number of companies lift their forward outlooks. Technology firms have stood out, with nearly one-third of...
08-14 02:35
Regeneron, Tenet leads top healthcare companies with highest earnings beats
As corporate earnings season progresses, investors are tracking sector performance metrics to gauge underlying healthcare demand and corporate efficiency. For the healthcare sector, spanning critical ...
08-12 18:54
High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocity against fu...
08-10 20:49
Biotech stocks lead healthcare's overbought list as earnings picks up
Healthcare stocks are in focus as second-quarter earnings season shifts into high gear, with investors evaluating whether recent rallies across biotech, medical technology and healthcare services can ...
07-23 19:18
Pharmaceuticals still a defensive play amid AI and geopolitical anxieties – analyst
Rajesh Kumar, head of European Life Sciences & Healthcare Equity Research at HSBC, positioned healthcare (XLV) as a defensive haven amid growing investor anxiety about AI investments and geopolitical ...
07-22 00:02
Citadel Securities: Market leadership broadens stumbles
Market leadership is showing clear signs of broadening, according to Citadel Securities’ Scott Rubner. Rather than exiting equities, investors are reallocating capital toward sectors that lagged in th...
07-13 23:13
Q2 watchlist: Healthcare stocks with perfect EPS revision scores
As Q2 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess demand across care delivery, diagnostics, life sciences, pharmaceuticals, medical devices, and...
07-10 22:52
Biotech rally rests on fundamentals, M&A appetite, says ROTY's Faison
The recent rally in biotechnology stocks is being driven by improving fundamentals and a resurgence in merger activity rather than speculative excess, according to Jonathan Faison, founder of ROTY Bio...
07-09 16:33
